Author

J. Benitez

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cell signaling & trafficking· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Approach:mechanistic / dynamical model· 1 Research Focus:metabolism & bioenergetics· 1

Frequent Co-Authors

A. I. Basbaum· 2 shared J. M. Braz· 2 shared A. I. Domingos· 1 shared A. Makriyannis· 1 shared B. C. Moraes· 1 shared B. K. Shoichet· 1 shared C. Iliopoulos-Tsoutsouvas· 1 shared C. Normand· 1 shared

Activity by Year

2023-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

A. I. Basbaum

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Meningeal Regulatory T cell-derived enkephalin gates nociception

E. Midavaine, B. C. Moraes, J. Benitez, S. R. Rodriguez, J. M. Braz, N. P. Kochhar, W. L. Eckalbar, A. I. Domingos, J. E. Pintar, A. I. Basbaum, S. W. Kashem

This study identifies meningeal regulatory T cells (mTregs) expressing enkephalin that modulate mechanical pain sensitivity in female mice via a sex hormone-dependent opioid receptor mechanism.

bioRxiv · May 11, 2024 · PreprintImmunology

Large library docking for cannabinoid-1 receptor agonists with reduced side effects

T. A. Tummino, C. Iliopoulos-Tsoutsouvas, J. M. Braz, E. S. O'Brien, R. M. Stein, V. Craik, N. K. Tran, S. Ganapathy, F. Liu, Y. Shiimura, F. Tong, T. C. Ho, D. S. Radchenko, Y. S. Moroz, S. R. Rosado, , B. K. Shoichet

The paper identifies a new cannabinoid-1 receptor agonist with reduced side effects through large library docking and experimental validation.

bioRxiv · Feb 27, 2023 · PreprintPharmacology & Toxicology